|
Author |
Subjects
| Analysis (study design) | Disease severity (mean FEV1 (% predicted)) | Comorbidity(ies) investigated | Detailed prescription of pulmonary rehabilitation program | Outcome(s) study | Response rates in patients with comorbidities (% of patients reaching MCID) |
|
Carreiro et al. [17] | | Retrospective (observational cross-sectional study) | | (i) Cardiovascular disease (68%) (ii) Metabolic disease (71%) (iii) Osteoporosis (11%) (iv) Anxiety and depression (21%)
| (i) Period: 8 weeks (3x/week) (ii) Duration/session: 30–45 minutes (iii) Intensity endurance training: 80% PWR
| (i) Dyspnea (MDI) (ii) Functional exercise capacity (6MWD) (iii) Quality of life (SGRQ)
| (i) Dyspnea: 49% (ii) Functional exercise capacity: 63% (iii) Quality of life: 63% |
Crisafulli et al. [16] | | Retrospective (observational cohort study) | | (i) Cardiovascular disease (24%) (ii) Metabolic disease (62%) (iii) Osteoporosis (7%)
| (i) Period: 20 sessions (3x/week) (ii) Duration/session: 3 hours (iii) Intensity endurance training: 70–80% PWR (iv) Strength training upper/lower body
| (i) Dyspnea (MRC) (ii) Functional exercise capacity (6MWD) (iii) Quality of life (SGRQ) | (i) Dyspnea: 82% (ii) Functional exercise capacity: 60% (iii) Quality of life: 58% |
Crisafulli et al. [18] | | Prospective (observational cohort study) | | (i) Cardiovascular disease (21%) (ii) Metabolic disease (56%) (iii) Osteoporosis (10%)
| (i) Period: 21 sessions (3x/week) (ii) Duration/session: 3 hours (iii) Intensity endurance training: 70–80% PWR (iv) Strength training upper/lower body
| (i) Dyspnea (MRC) (ii) Functional exercise capacity (6MWD) (iii) Quality of life (SGRQ) | (i) Dyspnea: 68% (ii) Functional exercise capacity: 60% (iii) Quality of life: 63% |
Walsh et al. [20] | | Retrospective (observational cohort study) | | (i) Cardiovascular disease (32%) (ii) Metabolic disease (28%) (iii) Osteoporosis (12%) | No detailed information | Functional exercise capacity (6MWD) | No detailed information |
|